Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Zero Based Budgeting in layman's terms makes this method accessible. Discover how to budget effectively by assigning every dollar a role.
20,130 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
When sandisk stock just dropped, it sent ripples through a volatile memory market. This article breaks down the drive...
U.S. Bancorp is emerging as a premier retirement safe haven thanks to a steady dividend, solid capital position and e...
NAIOP rebrands as CREDA, broadening its mandate to advocate, educate, and connect developers, owners, and investors a...
As pay-TV declines, Comcast may lean on first-party data to power targeted streaming ads. This article breaks down ho...
July can be a pivotal moment for travel stocks. Here are three clear reasons why Carnival stock may deserve a place o...
A senior insider at Septerna sold nearly 12,000 shares in a single move, raising questions for investors. This articl...
A trusted caretaker can become a financial risk for an aging loved one. This article breaks down how elder financial ...
A downgrade and AI chip headlines pushed Broadcom stock lower today. Here’s what happened, what it could mean, and pr...
A stock can jump this year, but chasing it blindly rarely ends well. This guide helps you assess whether the move jus...
Public disputes can derail a celebrity’s finances. This article uses a high-profile scenario to show you practical st...
CrowdStrike recently completed a stock split, sparking questions about its impact on liquidity and valuation. This gu...